CAP TWELVE

Brand	Owner	Address	Description
CAP12	Saluda Medical Pty Ltd	Level 1, 407 Pacific Highway Artarmon NSW 2062 Australia	CAP TWELVE; CAP ONE TWO;Pulse generators, implantable pulse generator and external pulse generators for medical use, namely, pulse generators for the purpose of delivering therapy for the management of chronic, intractable pain; neurostimulation leads that transmit electrical pulses to the spinal cord and record and transmit signals in response to electrical pulses for medical or treatment purposes; electrical pain management apparatus, namely, electrical neurostimulators; apparatus for medical and therapeutic stimulation of the body, namely, electrical neurostimulators;
	Where the owner name is not linked, that owner no longer owns the brand

Technical Examples

The present invention is directed to a method to prevent or reduce postoperative corneal subepithelial haze after excimer laser photorefractive keratectomy (PRK), laser in situ keratomileusis (LASIK) surgery. According to the method, a therapeutically effective amount of one or more plasminogen activators, most preferably urokinase (uPA), is administered topically to the surface of the affected eye at levels between 0.1 and 2,500 IU/ml, about eight to twelve times on the day of surgery, and four to eight times per day for about the next six to twelve days thereafter. The most preferred therapeutic amount is from about 0.1-1 IU uPA/ml, and also 1-10 IU/ml. Plasminogen activators that can be used in the inventions include urokinase, prourokinase, streptokinase and mutants thereof. The invention also covers topical ophthalmic compositions that include one or more plasminogen activators, most preferably uPA, to prevent or reduce postoperative corneal subepithelial haze.